VIDA VENTURES II-A, LLC
Insider CIK 1781930 · DYN 10% owner · AKTS 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AKTS Aktis Oncology, Inc. | C Conversion deriv | 2026-01-12 | 2026-01-12 | 3,648,750 | — | $0 | 0 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion deriv | 2026-01-12 | 2026-01-12 | 101,250 | — | $0 | 0 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion deriv | 2026-01-12 | 2026-01-12 | 411,750 | — | $0 | 0 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion deriv | 2026-01-12 | 2026-01-12 | 14,838,250 | — | $0 | 0 | SEC↗ |
| AKTS Aktis Oncology, Inc. | P Buy | 2026-01-12 | 2026-01-12 | 812,455 | $18.00 | $14.62M | 5,671,825 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion | 2026-01-12 | 2026-01-12 | 134,842 | — | $0 | 134,842 | SEC↗ |
| AKTS Aktis Oncology, Inc. | P Buy | 2026-01-12 | 2026-01-12 | 22,545 | $18.00 | $405.8K | 157,387 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion | 2026-01-12 | 2026-01-12 | 4,859,370 | — | $0 | 4,859,370 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion deriv | 2020-09-21 | 2020-09-23 | 6,922,803 | — | $0 | 0 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion deriv | 2020-09-21 | 2020-09-23 | 192,102 | — | $0 | 0 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion | 2020-09-21 | 2020-09-23 | 2,087,130 | — | $0 | 2,087,130 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | P Buy | 2020-09-21 | 2020-09-23 | 22,005 | $19.00 | $418.1K | 79,921 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | P Buy | 2020-09-21 | 2020-09-23 | 792,995 | $19.00 | $15.07M | 2,880,125 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion | 2020-09-21 | 2020-09-23 | 57,916 | — | $0 | 57,916 | SEC↗ |